Histamine H4 receptor agonists induce epithelial-mesenchymal transition events and enhance mammosphere formation via Src and TGF-β signaling in breast cancer cells-Reference-Cited by-同舟云学术

Histamine H4 receptor agonists induce epithelial-mesenchymal transition events and enhance mammosphere formation via Src and TGF-β signaling in breast cancer cells

Published:2020-10 Issue: Volume:180 Page:114177
ISSN:0006-2952
Container-title:Biochemical Pharmacology
language:en
Short-container-title:Biochemical Pharmacology

Author:

Galarza Tamara E.,Táquez Delgado Mónica A.,Mohamad Nora A.,Martín Gabriela A.,Cricco Graciela P.

Funder

Secretaría de Ciencia y Técnica de la Universidad de Buenos Aires

Publisher

Elsevier BV

Subject

Pharmacology,Biochemistry

Reference60 articles.

1. Cancer statistics;Siegel;CA Cancer J. Clin.,2016

2. The basics of epithelial-mesenchymal transition;Kalluri;J. Clin. Invest.,2009

3. Molecular mechanisms of epithelial-mesenchymal transition;Lamouille;Nat. Rev. Mol. Cell Biol.,2014

4. EMT: mechanisms and therapeutic implications;Singh;Pharmacol. Ther.,2018

5. International union of basic and clinical pharmacology. XCVIII. Histamine receptors;Panula;Pharmacol. Rev.,2015

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic potential of LINS01 histamine H3 receptor antagonists as antineoplastic agents for triple negative breast cancer;Biomedicine & Pharmacotherapy;2024-05

2. Histamine H4 Receptor Antagonist Ameliorates the Progression of Experimental Autoimmune Encephalomyelitis via Regulation of T-Cell Imbalance;International Journal of Molecular Sciences;2023-10-17

3. Histamine H4 Receptor Agonist, 4-Methylhistamine, Aggravates Disease Progression and Promotes Pro-Inflammatory Signaling in B Cells in an Experimental Autoimmune Encephalomyelitis Mouse Model;International Journal of Molecular Sciences;2023-08-20

4. Cancer stem cells and cellular plasticity: A preface to the special issue “Advances in understanding cancer stem cell biology and perspectives for targeted therapy”;Biochemical Pharmacology;2023-08

5. Signaling pathways governing the maintenance of breast cancer stem cells and their therapeutic implications;Frontiers in Cell and Developmental Biology;2023-07-10